|1.||El-Sherbeni, Ahmed A: 1 article (12/2015)|
|2.||El-Kadi, Ayman O S: 1 article (12/2015)|
|3.||Elshenawy, Osama H: 1 article (12/2015)|
|4.||Abdelhamid, Ghada: 1 article (12/2015)|
|5.||Elkhatali, Samya: 1 article (12/2015)|
12/15/2015 - "In conclusion, 19-HETE, incubated with cardiomyocytes in vitro or induced in the heart by INH in vivo, provides cardioprotection against Ang II-induced hypertrophy. "
12/15/2015 - "The effect of Ang II, with and without 19-HETE (20μM), on the development of cellular hypertrophy in cardiomyocyte RL-14 cells was assessed by real-time PCR. "
12/15/2015 - "Our results demonstrated that 19-HETE conferred a cardioprotective effect against Ang II-induced cellular hypertrophy in vitro, as indicated by the significant reduction in β/α-myosin heavy chain ratio. "
|2.||Cardiomegaly (Heart Hypertrophy)
12/15/2015 - "In the current study, we examined whether 19-HETE confers cardioprotection against angiotensin II (Ang II)-induced cardiac hypertrophy. "
12/15/2015 - "Also, cardiac hypertrophy was induced in Sprague-Dawley rats by Ang II, and the effect of increasing 19-HETE by isoniazid (INH; 200mg/kg/day) was assessed by heart weight and echocardiography. "
|3.||Hypertension (High Blood Pressure)
|1.||Myosin Heavy Chains (Myosin Heavy Chain)